deflazacort has been researched along with Weight Gain in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jefferies, JL; McMahon, MA; Rutter, MM; Rybalsky, I; Sawnani, H; Shellenbarger, KC; Tian, C; Wong, BL | 1 |
| Alman, BA; Biggar, WD; Mayo, AL; McAdam, LC | 1 |
| Campbell, C; Jacob, P | 1 |
| Ashwal, S; Baumbach, L; Connolly, A; Florence, J; Mathews, K; McDonald, C; Moxley, RT; Pandya, S; Sussman, M; Wade, C | 1 |
| Ansell, BM; David, J; Hesp, R; Loftus, JK; Reeve, J; Woo, PM | 1 |
1 review(s) available for deflazacort and Weight Gain
| Article | Year |
|---|---|
Deflazacort for the treatment of Duchenne Dystrophy: a systematic review.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Humans; Immunosuppressive Agents; Male; Muscle Contraction; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Randomized Controlled Trials as Topic; Treatment Outcome; Weight Gain | 2003 |
1 trial(s) available for deflazacort and Weight Gain
| Article | Year |
|---|---|
Deflazacort in juvenile chronic arthritis.
Topics: Absorptiometry, Photon; Analysis of Variance; Anti-Inflammatory Agents; Arthritis, Juvenile; Bone Density; Child; Chronic Disease; Double-Blind Method; Humans; Lumbar Vertebrae; Prednisone; Pregnenediones; Weight Gain | 1993 |
3 other study(ies) available for deflazacort and Weight Gain
| Article | Year |
|---|---|
Long-Term Outcome of Interdisciplinary Management of Patients with Duchenne Muscular Dystrophy Receiving Daily Glucocorticoid Treatment.
Topics: Adolescent; Age Factors; Child; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Exercise Therapy; Follow-Up Studies; Fractures, Bone; Glucocorticoids; Humans; Insulin Resistance; Long-Term Care; Male; Muscular Dystrophy, Duchenne; Osteoporosis; Patient Care Team; Prednisone; Pregnenediones; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome; Weight Gain | 2017 |
The Canadian experience with long-term deflazacort treatment in Duchenne muscular dystrophy.
Topics: Adolescent; Adrenal Cortex Hormones; Body Height; Bone Density; Canada; Cataract; Child; Fractures, Bone; Humans; Immunosuppressive Agents; Male; Muscle Strength; Muscular Dystrophy, Duchenne; Pregnenediones; Spinal Injuries; Spine; Walking; Weight Gain | 2012 |
Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
Topics: Adolescent; Child; Child, Preschool; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Muscular Dystrophy, Duchenne; Prednisone; Pregnenediones; Risk Assessment; Time; Weight Gain | 2005 |